Home > Helpful Treatment Tips > Using Artificial Tears With RESTASIS^®

• Helpful Treatment TipsAdvice for starting and staying on your RESTASIS^® therapy.
• Using Artificial Tears
  With RESTASIS^®Find out more about using RESTASIS^® with artificial tears.
• My Tears, My Rewards^® Program OverviewLearn how you can earn special offers and savings.

Using Artificial Tears With RESTASIS^®

The benefits of using RESTASIS^® Ophthalmic Emulsion will occur with continued use over time. While RESTASIS^® begins to increase tear production, you can continue to use artificial tears for relief of dry eye symptoms. Artificial tears for your various dry eye needs are available, including REFRESH^® Brand or REFRESH^® OPTIVE™ Lubricant Eye Drop products.

Many RESTASIS^® Ophthalmic Emulsion users may start to make more of their own tears within 1 month. One sign that your tear production may be increasing would be that you have less need to use artificial tears. Over the first 6 months of RESTASIS^® treatment, your use of artificial tears is likely to decrease.

Individual results may vary.

REFRESH^® Brand and REFRESH^®
OPTIVE™ Lubricant Eye Drops

Use either in conjunction with your
RESTASIS^® therapy

REFRESH^® drops help provide moisture for dry eyes.
Its fast-acting, long-lasting formula helps relieve your dry
eye symptoms

• Instantly moisturizes
• Relieves dry, irritated eyes

REFRESH^® OPTIVE™ relieves dry eyes two ways.
Its dual-action formula lubricates and hydrates
for longer-lasting comfort*

• Effectively treats dry eye symptoms
• Makes eyes feel better longer*
• Safely relieves and moisturizes
  *Longer lasting vs Systane^®.¹

Visit refreshbrand.com and optivesolutions.com
for more information and valuable savings.

Systane^® is a registered trademark of Alcon, Inc.

Reference
      1. Date on file. Allergan, Inc.

Next: Find out how you can save money on your RESTASIS^® prescription »

Indication:

RESTASIS^® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS^® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information:

RESTASIS^® Ophthalmic Emulsion should not be used by patients with active eye infections and has not been studied in patients with a history of herpes viral infections of the eye. RESTASIS^® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

Please see product information for RESTASIS^® Ophthalmic Emulsion.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

© 2010 Allergan, Inc. All rights reserved | Privacy Statement | FAQs | Terms of Use | Site Map | Contact Us
This information is intended for residents of the United States. ® and ™ marks owned by Allergan, Inc.